TUMOUR BIOMARKER AND PLASMA TIME COURSE DATA FROM ABIGAIL, A PHASE II STUDY OF 1ST-LINE BEVACIZUMAB plus CHEMOTHERAPY IN ADVANCED NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER (NS-NSCLC)

臺大醫院-內科部;Reck, M.M.ReckGorbunova, V. A.V. A.GorbunovaJuhasz, E.E.JuhaszSzima, B.B.SzimaOrlov, S.S.OrlovYu, C.C.YuPallaud, C.C.PallaudScherer, S. J.S. J.SchererArcher, V.V.ArcherMok, T. S. K.T. S. K.Mok2014-02-142018-07-112014-02-142018-07-112012http://ntur.lib.ntu.edu.tw//handle/246246/25908582 bytestext/html[SDGs]SDG3TUMOUR BIOMARKER AND PLASMA TIME COURSE DATA FROM ABIGAIL, A PHASE II STUDY OF 1ST-LINE BEVACIZUMAB plus CHEMOTHERAPY IN ADVANCED NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER (NS-NSCLC)http://ntur.lib.ntu.edu.tw/bitstream/246246/259085/1/index.html